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Abstract
Background: The use of autologous platelet-rich plasma (PRP) and plasma rich in growth factors (PRGF) has been
proposed for the treatment of several acute and chronic syndromes, such as corneal epithelial defects and dry eye
syndrome, gum bleeding during oral surgery, and in orthopaedic surgery. We hypothesized that PRGF, rather than
PRP, could be more effective because of its intrinsic characteristics in promoting the healing of intestinal
anastomosis. The purpose of the present study was to evaluate and compare the effects of PRP and PRGF on
various parameters of anastomotic healing in a swine model.
Methods: Eight female pigs were randomly assigned to two groups and subjected to hand sewn jeujuno-jejunal
appositional extramucosal anastomoses. For each animal, a total of six anastomoses were performed: two were
considered controls and received no treatment, while the remaining four anastomoses were treated with PRP or
PRGF of which both were prepared at a platelet concentration that was respectively 3.4-fold and 2.81-fold higher
than the original platelet count. In each animal, either PRP or PRGF was used as a treatment, to avoid interference
among products. Animals were euthanized after 8 days and the anastomoses were evaluated and compared for the
presence of adhesions, anastomotic leakage, bursting pressure, and histological appearance.
Results: The concentration of platelets in PRP was 3.41-fold higher (range, 3.20–4.24) that the concentration in
whole blood, while the concentration in PRGF was 2.81-fold higher (range, 2.89–4.88).
The results obtained from the present study highlighted that there are no differences between anastomotic
samples treated with either PRP or PRGF preparations, except for a significant increase in epithelization of the
intestinal mucosa at the anastomotic site in the PRGF group.
Conclusions: Both PRP and PRGF suspensions should be considered a safe strategy and represent a relatively low-
cost technology that is flexible enough to be applied in several therapeutic fields. No true benefit could be proven
in our study compared to the no treatment following anastomoses formation, with the exception of enhanced
epithelization of the mucosa in the PRGF group.
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Background
Surgical techniques are continuously evolving to be more
efficient for patients and to reduce the duration of post-
operative recovery. In gastrointestinal surgery, a major
challenge is represented by anastomosis dehiscence [1].
Recently, several studies have focused on identifying a
strategy to reduce this complication, which represents a
failure in the surgical procedure that can be potentially
fatal [2]. Some of these investigations have suggested using
substances that are able to accelerate the wound healing
process. Regenerative medicine may offer some important
guidance in this area [3]. The use of platelet-rich plasma
(PRP) alone or in combination with growth factors
(preparations rich in growth factors, PRGF) [4] naturally
secreted by platelets, such as platelet-derived growth
factor (PDGF), transforming growth factor-β (TGF-β), and
vascular endothelial growth factor (VEGF), may play a role
in improving anastomotic healing [3]. PRP and PRGF dif-
fer in composition and methods of preparation. Several
methods to produce a biologically active product have
been developed and they differ in the concentration of
growth factors, white blood cells, and characteristics of
the fibrin scaffold [5, 6]. PRP was defined by Ehrenfest et
al. [7] as a preparation with leucocytes and with a low-
density fibrin network after activation. PRGF contains
moderate platelet concentration, no leukocytes, nor a
three dimensional fibrin scaffold [5, 6]. From a therapeutic
perspective, there are two main advantages in using PRGF.
First is the release of proteins and growth factors from
platelets that stimulate regeneration. Second is the cre-
ation of a three-dimensional fibrin matrix that retains and
releases growth factors and acts as a temporal scaffold for
the cells [8]. Furthermore, the absence of leukocytes is an
important characteristic of PRGF. Leukocytes produce
metalloproteinase, free radicals, reactive oxygen species,
and nitrogen, which can cause damge to healing tissues
[8]. The rationale for PRP therapy lies in reversing the
blood ratio by reducing the amount of red blood cells,
which are less useful in the healing process, to approxi-
mately 5% and to increase the amount of platelets to 94%
to stimulate recovery [5]. The use of autologous PRP and
PRGF has been proposed for the treatment of several
acute and chronic syndromes, such as for corneal
epithelial defects and dry eye syndrome, avoiding gum
bleeding during oral surgery, and in orthopaedic surgery
[4, 9–12]. The most important feature of PRP is that au-
tologous products circumvent immunogenic reactions
and disease transmission. According to Dr. Anitua, who
first proposed the technique, PRGF has some peculiar
characteristics that may favour its use over that of PRP. In
particular, the lower number of leucocytes in the PRGF
may improve healing because of the absence of inflamma-
tory cells [13].
With each passing year, the number of relevant articles
published in PubMed has increased (accessed October 13,
2015); however it is difficult to compare all published re-
sults, given the lack of uniformity in processing platelets
and the different techniques used. Papers dealing with the
possible use of PRP have not been in complete agreement.
The majority suggest that these substances have a positive
effect on wound healing of colonic anastomosis, while one
paper [3] indicated that application of PRP could only
increase fibrosis and granulation tissue, without improving
the breaking strength of anastomotic sites. To date, all
studies have dealt with PRP, while none have tested the
use of PRGF on anastomosis healing.
Our hypothesis was that PRGF, rather than PRP, could
be more effective in promoting the healing of intestinal
anastomosis because of its intrinsic characteristics (i.e.,
low number of leukocytes). The purpose of the present
study was to evaluate and compare the effects of PRP
and PRGF on various parameters of anastomotic healing
in a swine model.
Results
Assessment of the characteristics of autologous
preparations
Results from assessing the characteristics of the autolo-
gous preparations are reported in Table 1. The concentra-
tion of platelets and leukocytes of freshly collected whole
blood for both groups were within the normal range of
values for Landrace pigs (platelets 217–770 × 103/mL, leu-
kocytes 7–20 × 103/mL) (http://www.ahc.umn.edu/rar/
refvalues.html, accessed 15-06-2017). The concentration
of platelets in PRP was 3.41-fold higher (range, 3.20–4.24)
Table 1 Comparison of the characteristics of the preparations (median-range)
Group PRP Group PRGF
Whole blood
(cells ×103/ μL)
PRP
(cells ×103/ μL)
Prep/WB ratio Whole blood
(cells ×103/ μL)
PRGF
(cells ×103/ μL)
Prep/WB ratio
Platelet count 387
(295–622)
1321
(945–2641)
3.4
(2.5–4.9)
376
(285–495)
1565
(825–2420)
3.4
(1.5–5.3)
Leukocyte Count 13.76
(11.5–17)
1.72a
(0.8-3.5)
0.132b
(0.05-0.20)
13.85
(10.2–16)
0.17a
(0.01-1.020)
0.02b
(0.001-0.67)
aP = 0.0007
bP = 0.0002
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than the concentration of whole blood, while in PRGF, it
was 2.81-fold higher (range, 2.89–4.88).
Surgical procedures
All animals recovered uneventfully from anaesthesia and
there were no surgery-related complications in the post-
operative period
Macroscopic examination
Macroscopic evaluation showed no evidence of leaking in
any anastomoses in either the control or treated animals.
Anastomoses treated with PRP showed more adhesion
formation (10/16) compared to those treated with PRGF
(5/16) or controls (6/16); nevertheless, this increase in
adhesion formation was not significantly different
(P = 0.169). When adhesion formation was noted, it was
scored 1 or 2, with only one case in the PRP group that was
scored 3 (Fig. 1). The median adhesion score for group PRP
was 1 (0–3) and 0 for group PRGF (0–2).
Bursting pressure
Bowel sections treated with PRGF demonstrated more re-
sistance at the bursting pressure test (Table 2), although
not significantly different from controls and PRP-treated
anastomoses. PRP-treated anastomoses were significantly
less resistant than intact intestinal tissue.
Histology
Results of the histological evaluation are reported in
Table 3. There was no significant difference among the
samples treated with PRP, PRGF, and controls relative to
inflammatory infiltrate, proliferation of fibroblasts,
neovascularisation, or deposition of collagen (Fig. 2).
Microscopic evaluation highlighted a significant increase
in epithelization of the mucosa in the PRGF-treated group
(Table 3)
Discussion
During the early stages of intestinal wound healing,
platelets play an important role during the initial 72 h
after injury [14]. The release of growth factors from plate-
lets mediates the healing process [15]. The use of autolo-
gous substances, such as platelet rich products, has been
considered a promising advance for new surgical and
clinical approaches. Furthermore, recent advances in their
use should eliminate the risk of immunological reactions.
Moreover, it is assumed that they increase the local
growth factor concentrations at the site of healing, thereby
accelerating the wound healing process [15]. This type of
biological treatment mimics natural tissue healing, while
optimising and reducing the time required [5]. Thus, all
proteins necessary for tissue repair are released locally.
To the best of our knowledge, this is the first study
comparing PRP and PRGF healing effects on intestinal
anastomosis.
Bursting pressure is considered to be a more accurate
measure as it reflects the physiologic strain in intestinal
tissue rather than than the breaking strength [15]. Intestinal
healing is characterised by three phases of healing: inflam-
matory, proliferative, and the maturation phases. These
steps occur between post-operative days 0 and 4, from days
3 to 14, and from days 10 to 180, respectively [15]. Usually,
during the first phase, fibrin contributes to wound healing
and strength, but the major strain is allocated to the
sutures. In a normal setting, between days 3 and 4, the
anastomotic strength is lower due to fibrinolysis and colla-
gen deposition. Under such conditions, dehiscence of the
suture line can easily occur. This study considered only the
proliferative phase because all pigs were euthanized at day
8 after surgery. We specifically took into consideration this
period because, in this phase, macrophages are involved in
fibrin debridement (occurring in the inflammatory phase)
and natural growth factor production is at its maximum
peak and might modulate fibrosis and angiogenesis [16].
Fig. 1 A grade 3 adhesion in the PRP group
Table 2 Bursting pressure measurements (median-range)
PRP-treated
anastomoses
PRGF-treated
anastomoses
Control
anastomoses
Intact
bowel
Bursting
pressure
117.5
(80–190)a
165
(100–190)
154.0
(50–180)
175
(160–190)a
aP = 0.0007
Table 3 Results of the histological evaluation (median-range)
PRGF PRP Control p value
Epithelization 2.5 (0–3)a,b 1 (0–2)a 0.5 (0–2)b a = 0.0012
b = 0.0005
Inflammation 3 (1–3) 2.5 (2–3) 3 (1–3) 0.668
Fibrosis 2 (1–3) 3 (1–3) 3 (1–3) 0.135
Neovascularization 1 (0–2) 2 (1–3) 2 (1–3) 0.079
Collagen 2.5 (1–3) 2 (1–3) 2 (1–3) 0.971
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The application of a PRP or a PRGF treatment should pro-
mote intestinal healing and lower the risk of dehiscence.
The results obtained from the present study highlighted
that there are no significant differences between anasto-
motic samples treated with either PRP or PRGF prepara-
tions. Bursting pressure showed a high resistance of PRGF-
treated anastomoses, in comparison with PRP treated ones.
A statistical significance was found between the PRP-
treated anastomoses and the healthy intestine. This finding
could be due to the presence of leukocytes in the PRP,
which release substances (such as metalloproteinases) that
may damage healing tissues. Leukocytes, by participating in
an inflammatory cascade, could decrease anastomotic
bursting pressure more so than in the control anastomoses,
where leukocytes concentration is lower. During the prolif-
erative phase, an increase in neo-vascularisation, fibroblast
proliferation, and collagen deposition should be noted
along with a decrease in inflammation. However, in our
study, no difference was found between groups regarding
these parameters. Our results showed only a better
epithelization of the jejunal mucosa in the PRGF-treated
group. The data from this study are partially in accordance
with the results of Fresno et al. [3]. The authors employed a
similar experimental design, but, following treatment of the
anastomosis with the PRP suspension, the anastomotic sites
were covered with omentum. This could cause an increase
in fibrosis at the anastomotic sites that could be considered
a bias. In the present study, in order to avoid this type of
interference, the omentum was not placed on the anasto-
mosis site.
In our study anastomoses treated with PRP showed
more adhesion formation compared to samples treated
with PRGF or controls. These results could be explained
by the composition of the PRP, which contains leuko-
cytes and platelets. Adhesion formation is triggered by
inflammatory mediators and by dispersion of fibrin onto
the affected surface [17]. Converseley, as reported by
Anitua et al. [6], who first proposed the technique, PRGF
was found to not contain any leukocytes. Instead, PRGF
was found to contain a moderate platelet concentration,
Fig. 2 Histological appearance of the anastomotic site in each group: a,b CONTROL. c,d PRGF. e,f PRP, Bar: 100 μ, a, c, e Hematoxylin and eosin
10×. b, d, f trichrome Masson staining 10×, *Inflammation, Black Arrow: epithelization, White arrow: fibrosis
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which would circumvent all potential pro-inflammatory
effects that could explain the higher number of
adhesions in the PRP group.
As already argued by Fresno et al. [3], the immersion of
the intestinal edges in the treatment bath may present some
issues. Intestinal edges after a resection usually bleed, and
may be contaminated with intestinal contents, thus poten-
tially influencing PRP or PRGF efficiency and concentration.
Some authors [18, 19] have investigated platelet rich
plasma and considered eliminating leukocytes from such
preparation so as to avoid higher concentrations of pro-
inflammatory cytokines that might reduce tissue healing.
The study by Anitua et al. [12] used PRP that was either
rich or poor in leucocytes in order to evaluate whether
this could influence tissue healing; however, it appeared
that leucocyte concentrations did not interfere with
wound healing after oral surgery. Some issues were raised
by Del Buono and colleagues [20] against the indiscrimin-
ate use of PRP or PRGF. They explained that these
substances could successfully improve wound healing in
orthopaedic and oral surgery, but should be carefully han-
dled for other applications, because concentrations of PRP
or PRGF, doses, timing and length of applications have
not been defined yet. Yamaguchi et al. [15] investigated
different concentrations of PRP to evaluate dose-specific
effects on intestinal anastomosis in rats and established
that the optimal concentration of platelets should be
around 2.5-fold higher than that found in the initial blood
collection. As also reported by Yamaguchi et al. [15], clini-
cians should be cautious in thinking “if some is good,
more is better” as it does not apply to PRP applications. It
has been shown that platelet concentrations of 4.5–5.5-
fold higher than that found in whole blood may interfere
with the normal wound healing process [14, 21]. In our
study, platelet concentrations achieved in both groups
(PRGF and PRP) were 3.4- and 3.5-fold higher, respect-
ively, than the initial ratio. This is higher than what is
considered the optimal ratio to achieve a maximum effect
from plasma-rich preparations on intestinal anastomosis
[15] and perhaps this could be the cause of the poor effect
demonstrated in our study. Reducing the platelet concen-
tration to around 2.5-times the plasma concentration or
changing the method of its application at the anastomotic
site may yeld different results.
Fresno and colleagues [3] did not find a significant
difference in breaking strength when PRP was applied to
anastomoses in pigs, but they found a higher degree of
fibrosis and granulation tissue. While the finding on burst-
ing pressure is in accordance with our study, the difference
between their histological findings and ours may be due to
a certain degree of subjectiveness in the evaluation. Yol and
colleagues [22] instead found that PRP application in-
creased the bursting strength of intestinal anastomoses in
rats. In this case, the difference with our study may be due
to differences in species (rat vs pig), intestinal segment
(colon vs jejunum) and method of production of PRP.
Certainly, as in the study conducted by Fresno and col-
leagues, our study is limited from having tested the two
treatments together with the control in the same animal. It
is possible that this was a confounding factor and that,
eventually, resulted in growth factors from one preparation
effecting sites that were distant from the application site.
Further studies are needed to prove the effectiveness
of platelet rich preparations in species other than rats
and in different intestinal segments. Furhtermore,
methods that could modulate the final concentration of
platelets in the preparation would be beneficial.
Conclusions
Both PRP and PRGF suspensions should be considered a
safe strategy and represent a relatively low-cost technology
that are flexible enough to be applied in several thera-
peutic fields. No true benefit could be proven in our study
compared to the no treatment following anastomoses
formation, with the exception of enhanced epithelization
of the mucosa in the PRGF group. Nevertheless, further
studies are required to clarify the molecular mechanisms
underlying the biological effects on wound healing and to
understand how to improve this promising tool.
Methods
The study was approved by the Bioethical Committee of the
University of Turin and by the Italian Ministry of Health.
Animals
Eight female pigs (Landrace X Large White), weighing 40
to 48 kg, were kept in standard conditions and fed for
1 week before the experiment. Pigs were randomly assigned
to two groups (PRP and PRGF) and subjected to hand sewn
jejuuno-jejunal appositional extramucosal anastomoses
[22]. For each animal, a total of six anastomoses were
performed: two were considered controls and received no
treatment, while the remaining four anastomoses were
treated with PRP or PRGF, according to the assigned group.
In each animal, either PRP or PRGF was used as a treat-
ment, to avoid interference among products. This led to a
total of 16 untreated anastomoses (control), 16 anasto-
moses treated with PRGF, and 16 treated with PRP.
PRP preparation
For all pigs in the PRP group, blood samples were collected
from the jugular vein before surgical procedures, just before
induction of anaesthesia. For each pig, 5 mL blood samples
were drawn into 12 different tubes containing buffered
3.8% sodium citrate. Blood samples were centrifuged at
786 g for 10 min. Next, supernatant and buffy coat were
removed and the remaining sample was centrifugated at
526 g for 10 min. The resulting pellet consisted of platelets,
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which were harvested and re-suspended with 500 μL of
supernatant. The suspension was then stored at 20 °C for a
time ranging between 45 and 90 min before being applied
to the anastomotic site. Immediately prior to the applica-
tion at the anastomotic site, 1 mL of this suspension was
transferred to a Petri dish and 50 μL of calcium chloride
(25 mM) was added to activate the PRP [3].
PRGF preparation
Similar to the pigs in the PRP group, blood was collected
from all pigs in the PRGF group from the jugular vein just
before induction of anaesthesia. For each pig, 5 mL blood
samples were drawn into 12 different tubes containing
buffered 3.8% sodium citrate. Samples were then centri-
fuged using a PRGF-endoret system1 at 580 g for 8 min.
This procedure led to the separation of the different
fractions: the first (Fraction 1: F1) containing a platelet
count similar to that of peripheral blood, the second (F2)
containing a higher quantity of platelets and growth
factors, and the third (F3) containing the highest concen-
tration of both platelets and growth factors compared to
other fractions. F3 was the only fraction useful for the
preparation of PRGF, while F1 and F2 were discarded [4].
Immediately prior to application at the anastomotic site,
1 mL of suspension, prepared as described above, was
transferred to a Petri dish and 50 μL of 10% calcium
chloride was added to activate the preparation [5].
For both PRP and PRGF suspensions, both platelet and
white blood cell counts were obtained and compared.
Group assignment
Animals and techniques were assigned randomly, using
a random number generator (www.random.org).
Assessment of the characteristics of the autologous
preparation
The number of platelets and leukocytes in swine whole
blood (before centrifugation) and in PRGF and PRP
fractions was assessed using the Advia 120 Bayer Haema-
tology Analyser1.2 Because each autologous preparation
(PRP and PRGF) was obtained from animals of two
groups, a ratio between the platelet (PLT) count in each
preparation and the platelet count of the whole blood
(WB) was calculated for each group for comparison pur-
poses using the formula: PLT ratio = (PLT count in autolo-
gous preparation/PLT in whole blood). Similarly, the ratio
between the number of leukocytes in the preparation and
the number of leukocytes in the whole blood was obtained
using the formula: Leukocyte ratio = Leucocyte count in
autologous preparation/Leukocytes in whole blood.
In addition, the collection efficiency (%) was calculated
as follows: (Preparation volume × preparation PLT count)/
(Whole blood volume × Whole blood PLT count) × 100
[3] and was compared between groups.
Surgical procedures
Twelve hours before surgery, animals were not allowed to
consume food, but were allowed to consume water ad libi-
tum. Pigs were pre-medicated with an intramuscular in-
jection of xylazine23 (2 mL/kg, intramuscularly [IM]) and
anaesthesia was induced using an intramuscular injection
of tiletamine and zolazepam34 (4.4 mg/kg, intramuscularly
[IM]). The trachea was intubated and anaesthesia was
maintained with 2–2.5% isoflurane45 in 100% oxygen and
spontaneous ventilation, with a semi-closed circular
anaesthetic system. Animals were placed in dorsal recum-
bency and the abdomen was shaved and aseptically pre-
pared using 10% povidone iodine. After a midline
laparotomy, the small intestine was exposed. At 30 cm
distally from the Treitz’s ligament, six resections were per-
formed on the jejunum, approximately 40 cm apart.
The methods by which resection and anastomosis forma-
tion were performed were standardized to limit the harvest-
ing of tissue such that there would be no differences in
vascularization. A wedge of tissue was obtained by cutting
the intestine along two lines at an angle of 60° starting at
the same mesenteric site. The anastomotic technique was
the same for all anastomoses and was performed by a single
surgeon (MG). Resection and anastomosis was performed
extracorporeally and moist laparotomic gauzes were used
to reduce surgical field contamination
Before anastomosing the two segments, the edges were
dipped in the activated PRP or PRGF, according to the
allocated group, and maintained for 5 min until the
preparation formed a gelatinous clot [3]. The surgeon
performing the anastomoses was blinded regarding the
treatment. Being careful not to remove this clot, intes-
tinal continuity was then restored with a jejuno-jejunal
end-to-end anastomosis, using a single-layer continuous
modified appositional extra-mucosal suture [22] with a
Glycomer 631 USP 3–05.6
As described above, two anastomoses in each subject
were used as controls. The intestinal stumps were
dipped in 0.9% sodium chloride solution for 5 min be-
fore application to the anastomosis sites.
No measures were undertaken to reduce the risk of
adhesions, other than keeping the intestine moistened
during the procedure and, in particular, the anastomotic
sites were not covered with omentum. The mesentery
was closed with a simple continuous suture with Glyco-
mer 631 USP 3-0.5, 6
The abdomen was closed using a routine, mass simple
continuous suture of the fascia with PDS USP 167 and
with stapled closure of the skin using staples6,7.8 Animals
were treated preoperatively with a single intramuscular
administration of benzipenicillin-diistreptomicine6,7,89
(20 mg/kg, intramuscularly [IM]), while post-operative
analgesic therapy consisted of intramuscular buprenor-
phine7,8,910 (0.01 mg/kg, intramuscularly [IM]) once and
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as needed based upon postoperative monitoring. During
recovery, pigs were placed under an infrared heat lamp.
After recovery, access to water and food was allowed
after 6 and 18 h, respectively.
Postoperatively, pigs were monitored twice daily for
fever and pain (which were determined by monitoring
the animal’s appearance, food intake, activity, and
response to wound palpation).
All animals were anaesthetised 8 days after surgery
using an intramuscular injection of tiletamine and zolaze-
pam3,4 (4.4 mg/kg, intramuscularly [IM]) and euthanized
by intracardiac injection of embutramide, mebenzonium
iodide, and tetracaine hydrochloride solution8,9,1011.12
Postoperative period
All animals recovered uneventfully from anaesthesia.
Only two pigs showed postoperative pain that was con-
trolled by further doses of buprenorphine.
Macroscopic examination
Necropsy was performed by an operator blinded to the
techniques. During the necropsy, the following findings
were recorded: a) adhesions; b) signs of peritonitis; c)
anastomotic leakage; and d) presence of abscesses or granu-
lomas at the anastomotic sites. The number of adhesions
involving the anastomoses was determined and compared
within groups.
The evaluation of adhesions in each anastomotic site was
classified according to the scale proposed by Van der Ham
et al. [23] and by Wang and colleagues [24] (Table 4).
Bursting pressure
Directly after euthanasia and necropsy, tThe bursting
pressure was measured using a modified inflation tank test
[25, 26]. Intestine portions were closed with plastic tie-
wraps that were placed 10 cm proximally and distally to the
anastomotic site. At one end, a 20 G needle, attached to a
column manometer, was tunnelled through the intestinal
wall. Similarly, at the opposite end, another 20 G needle
was inserted and attached to a syringe pump. The specimen
was maintained in 0.9% warm saline as the syringe
pump11,1213 inflated the tissue with air at a rate of 0.5 L/
min. The procedure was digitally filmed. Anastomotic
leakage and bursting were indicated by the presence of air
bubbles and by a sudden pressure stop/drop, as measured
by a manometer. The exact peak pressure was reported
with the help of videography [25]. The bursting pressures
of healthy intestinal samples distant from the anastomotic
sites during necroscopy were also recorded as controls [27].
All samples were sectioned longitudinally on the anti-
mesenteric margin and fixed in 10% buffered formalin.
Histology
Bowel samples were fixed in 10% buffered formalin, embed-
ded in paraffin, cut into 4-μm sections, stained with haema-
toxylin and eosin (H&E), and examined by two blinded
expert pathologists to evaluate inflammation and neovascu-
larisation. Sample slices were also stained with Masson’s
trichrome to assess fibroblast proliferation. Each parameter
(i.e., epithelialization/ulceration, inflammatory infiltrate,
proliferation of fibroblasts, neovascularization, and depos-
ition of collagen) was scored on a scale proposed by Erlich
et al. and modified by Philips et al. [28, 29] (Table 5).
Statistical analysis
Data are presented as median (range). Normality of data
was determined by the Shapiro-Wilk test. To compare
platelet and leukocyte counts, an unpaired Student’s t-test
with Welch’s correction was used, while the Mann–Whit-
ney test was employed to compare ratios. The Kruskal–
Wallis test with Dunn’s multiple comparison tests was used
to compare bursting pressures and histological parameters.
The number of adhesions per group was compared
using the Chi square test, while the mean adhesion score
for each group was compared using the Kruskal–Wallis
test with Dunn’s post-hoc test. Data were analysed using
GraphPad Prism 6.0 software9 software12,13 and a P-value
<0.05 was considered significant.
Endnotes
1BTI Biotechnology Institut, Milano, Italy
2Siemens AG, Wittelsbacherplatz, Munich, Germany
3Bayer Animal Health, Monheim, Nordrhein-Westfalen,
Germany
4Virbac Italia, Milano, Italy
5Esteve Italia spa, Milano, Italy
6Covidien, Segrate Milano, Italy
7Johnson and Johnson, Milano, Italy
Table 4 Grading of adhesions
Score Description
0 No adhesion
1 Minimal adhesions, mainly between the
anastomosis and omentum
2 Moderate adhesion, between omentum
and anastomosis, or between the bowel
and anastomosis
3 Severe and extended adhesions with
possible formation of abscesses
Table 5 Grading of histological parameters
Score Description
0 No evidence
1 Occasional evidence
2 Light scattering
3 Abundant evidence
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8Weck Visistat R35
9Fatro, Ozzano dell’Emilia, Italy
10Schering-Plough, Segrate Milano, Italy
11Intervet Italia srl, Segrate Milano, Italy
12Care Fusion, Firenze, Italy
13GraphPad Software Inc., La Jolla, USA
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